Lupin announced today the completion of the acquisition of a portfolio of brands from Anglo-French Drugs & Industries (AFDIL) and its Associates.
The acquisition will strengthen Lupin's India Formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products. The acquisition of the AFDIL brands takes Lupin further in shaping its portfolio to emerge as a leading pharmaceutical company in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
